Differences in VEGF/VEGFR status and key molecules and cells in the tumor microenvironment between NF2 and non-NF2 schwannomas, and between NF2 schwannomas pre-vaccination and post vaccination, are also analyzed. This evidence concerns the gene VEGFA and neoplasm.